Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP6076033B2 - Chemical volatilization container - Google Patents
[go: Go Back, main page]

JP6076033B2 - Chemical volatilization container - Google Patents

Chemical volatilization container Download PDF

Info

Publication number
JP6076033B2
JP6076033B2 JP2012235905A JP2012235905A JP6076033B2 JP 6076033 B2 JP6076033 B2 JP 6076033B2 JP 2012235905 A JP2012235905 A JP 2012235905A JP 2012235905 A JP2012235905 A JP 2012235905A JP 6076033 B2 JP6076033 B2 JP 6076033B2
Authority
JP
Japan
Prior art keywords
pedestal
ring
lid
shaped member
volatilization container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012235905A
Other languages
Japanese (ja)
Other versions
JP2014050666A (en
Inventor
裕之 三浦
裕之 三浦
勇人 井實
勇人 井實
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Priority to JP2012235905A priority Critical patent/JP6076033B2/en
Publication of JP2014050666A publication Critical patent/JP2014050666A/en
Application granted granted Critical
Publication of JP6076033B2 publication Critical patent/JP6076033B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Packaging Of Annular Or Rod-Shaped Articles, Wearing Apparel, Cassettes, Or The Like (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)

Description

本発明は、芳香剤、消臭剤などの種々の揮散性を有する薬剤を揮散させる薬剤揮散容器に関する。   The present invention relates to a chemical volatilization container that volatilizes chemicals having various volatility such as fragrances and deodorants.

室内や自動車などの空間の臭気による不快感をなくし、快適な空間を生み出すために、薬剤を自然に揮散させる薬剤揮散容器が広く使用されている。この薬剤揮散容器には、ゲル状、固形状、液状など、種々の薬剤が用いられており、その中で保形性のあるゲル状薬剤を用いた薬剤揮散容器として、例えば特許文献1に記載のものが知られている。この特許文献1に記載の薬剤揮散容器は、図31(a)、(b)に示すように、ゲル状薬剤100を載置する台座部101を有し、下端が開口するカップ状の蓋部102により薬剤100が覆われた構成となっている。蓋部102の周壁103には揮散孔104が設けられ、蓋部102内に収納された薬剤100が徐々に揮散することにより、揮散した薬剤が揮散孔104から外部に放出され、薬効が得られる。   In order to eliminate the discomfort caused by odors in rooms and automobiles and create a comfortable space, drug volatilization containers that volatilize drugs naturally are widely used. Various chemicals such as gel, solid, and liquid are used in the chemical volatilization container. Among them, as a chemical volatilization container using a gel-like chemical having shape retention, for example, described in Patent Document 1 Things are known. As shown in FIGS. 31A and 31B, the drug volatilization container described in Patent Document 1 has a pedestal part 101 on which the gel-like drug 100 is placed, and a cup-shaped lid part whose lower end is open. The medicine 100 is covered with 102. The volatilization hole 104 is provided in the peripheral wall 103 of the cover part 102, and when the chemical | medical agent 100 accommodated in the cover part 102 volatilizes gradually, the volatilized chemical | medical agent is discharge | released outside from the volatilization hole 104, and a medicinal effect is acquired. .

実公昭57−1950号公報Japanese Utility Model Publication No.57-1950

しかしながら、上記した特許文献1に記載の薬剤揮散容器では、蓋部102の下端開口内に台座部101を嵌合することで台座部101と蓋部102とを固定するように構成されているため、薬剤揮散容器が倒れたりすると、容易に台座部101と蓋部102との固定が外れ、台座部101と蓋部102との隙間から内部のゲル状薬剤100から吐き出されて遊離した水分の一部が漏れ出してしまうという課題があった。また、蓋部102内が台座部101により完全に密閉されていると、使用前に蓋部102内の酸素が消費されることで、蓋部102内が減圧し、その結果、蓋部102の周壁103の一部が凹むという課題もある。   However, the drug volatilization container described in Patent Document 1 is configured to fix the pedestal 101 and the lid 102 by fitting the pedestal 101 in the lower end opening of the lid 102. When the chemical volatilization container falls down, the pedestal 101 and the lid 102 are easily detached from each other, and one of the released water is discharged from the gel-like drug 100 inside through the gap between the pedestal 101 and the lid 102. There was a problem that the part leaked out. Further, if the inside of the lid portion 102 is completely sealed by the pedestal portion 101, oxygen in the lid portion 102 is consumed before use, and the inside of the lid portion 102 is depressurized. As a result, the lid portion 102 There is also a problem that a part of the peripheral wall 103 is recessed.

本発明は、上記した課題に着目してなされたもので、台座部と蓋部とを確実に固定することができる薬剤揮散容器を提供することを目的とする。   The present invention has been made paying attention to the above-described problems, and an object of the present invention is to provide a chemical volatilization container that can securely fix a pedestal portion and a lid portion.

本発明の上記目的は、下端が開口し内部に薬剤を収納可能な空間を有し、周壁に薬剤を揮散させる揮散孔を有する蓋部と、前記薬剤を載置するとともに、前記薬剤を収納した前記蓋部の下端開口を塞ぐ台座部と、前記台座部の周縁と係合し、前記台座部上に前記蓋部を固定するリング状部材と、を備え、前記蓋部の下端開口の周縁には外方に延出するフランジ部が設けられ、前記リング状部材は、前記台座部の上面とで前記フランジ部を上下から挟持することを特徴とする薬剤揮散容器により達成される。   The object of the present invention is to open the lower end and have a space in which the medicine can be stored, and to have a lid portion having a volatilization hole for volatilizing the medicine on the peripheral wall, and to place the medicine and to house the medicine. A pedestal that closes the lower end opening of the lid, and a ring-shaped member that engages with the periphery of the pedestal and fixes the lid on the pedestal, and on the periphery of the lower end opening of the lid Is provided with a flange portion extending outward, and the ring-shaped member is achieved by a chemical volatilization container characterized in that the flange portion is sandwiched from above and below with the upper surface of the pedestal portion.

上記構成の薬剤揮散容器によれば、蓋部の下端開口を塞ぐ台座部に対して上方からリング状部材を被せ、リング状部材と台座部の周縁とを係合させることにより、蓋部内を密閉した状態で蓋部を台座部上に固定することができる。このとき、蓋部は、フランジ部が台座部の上面とリング状部材とで上下から挟持されているので、蓋部を確実に台座部に固定できる。よって、誤って薬剤揮散容器が倒れたりした場合でも、台座部と蓋部との固定が外れることがなく、また、蓋部内に収納された薬剤から吐き出されて遊離した水分の一部が外部に漏れることを抑制・防止できる。また、フランジ部が台座部の上面とリング状部材とで挟持されることで、蓋部内を良好に密閉することができる。薬剤揮散容器を使用開始するときには、揮散孔を介して蓋部内に収納された薬剤を徐々に外部に揮散させることにより、薬剤の薬効が得られる。   According to the chemical volatilization container with the above configuration, the pedestal that closes the lower end opening of the lid is covered with the ring-shaped member from above, and the ring-shaped member and the periphery of the pedestal are engaged to seal the inside of the lid. In this state, the lid can be fixed on the pedestal. At this time, since the lid portion is sandwiched from above and below by the upper surface of the pedestal portion and the ring-shaped member, the lid portion can be reliably fixed to the pedestal portion. Therefore, even if the medicine volatilization container falls down accidentally, the pedestal part and the lid part do not come off, and some of the moisture released from the medicine stored in the lid part is released to the outside. Leakage can be suppressed / prevented. Moreover, the inside of a cover part can be favorably sealed because a flange part is clamped by the upper surface of a base part, and a ring-shaped member. When starting to use the chemical volatilization container, the medicinal effect of the chemical is obtained by gradually volatilizing the chemical stored in the lid through the volatilization hole.

上記構成の薬剤揮散容器において、前記台座部には、前記蓋部の収納空間の内外を連通する連通部が設けられていることが好ましい。上記構成の薬剤揮散容器においては、使用前に蓋部内の酸素が消費されることで、蓋部内が減圧し、その結果、蓋部の一部が凹んでしまう。蓋部の一部が凹むと、薬剤揮散容器の見栄えが悪くなり、薬剤が蓋部内に未だ残った未使用の状態で薬剤揮散容器が廃棄処分されてしまうような無駄が生じることがある。この構成の薬剤揮散容器によれば、台座部に蓋部の収納空間の内外を連通する連通部が設けられ、連通部を介して収納空間内外の空気の流通が可能になっているので、使用前に蓋部内が減圧して蓋部の一部が凹むことを防止できる。その結果、上記した問題点を解決することができる。   In the chemical volatilization container having the above configuration, it is preferable that the pedestal portion is provided with a communication portion that communicates the inside and outside of the storage space of the lid portion. In the chemical volatilization container having the above-described configuration, the oxygen in the lid is consumed before use, whereby the inside of the lid is depressurized, and as a result, a part of the lid is recessed. When a part of the lid is recessed, the appearance of the chemical volatilization container is deteriorated, and waste such that the chemical volatilization container is discarded in an unused state in which the chemical is still left in the lid may occur. According to the chemical volatilization container with this configuration, the pedestal portion is provided with a communication portion that communicates the inside and outside of the storage space of the lid portion, and air can be circulated inside and outside the storage space via the communication portion. It is possible to prevent the inside of the lid from depressurizing and a part of the lid from being recessed. As a result, the above problems can be solved.

また、前記台座部の上面には、上面から突き出る環状のコンタクトリングが設けられており、前記フランジ部は、前記コンタクトリングと前記リング状部材とで上下から挟持されることが好ましい。この実施態様によれば、台座部の上面にコンタクトリングを設けることで、蓋部のフランジ部がコンタクトリングの上面とリング状部材とで強固に挟持されるので、蓋部を台座部上にしっかりと液密に固定することができる。   Further, it is preferable that an annular contact ring protruding from the upper surface is provided on the upper surface of the pedestal portion, and the flange portion is sandwiched from above and below by the contact ring and the ring-shaped member. According to this embodiment, by providing the contact ring on the upper surface of the pedestal portion, the flange portion of the lid portion is firmly held between the upper surface of the contact ring and the ring-shaped member. And can be fixed liquid-tight.

なお、台座部の上面にコンタクトリングを設けることに代えて、台座部の上面にリング状のパッキンを設け、フランジ部を、パッキンを介して台座部とリング状部材とで上下から挟持するように構成してもよい。この実施態様によれば、台座部の上面にパッキンを設けることで、蓋部のフランジ部がパッキンと当接するので、蓋部を台座部上により液密に固定することができる。   Instead of providing a contact ring on the upper surface of the pedestal part, a ring-shaped packing is provided on the upper surface of the pedestal part, and the flange part is sandwiched between the pedestal part and the ring-shaped member via the packing from above and below. It may be configured. According to this embodiment, by providing the packing on the upper surface of the pedestal portion, the flange portion of the lid portion comes into contact with the packing, so that the lid portion can be more liquid-tightly fixed on the pedestal portion.

上記構成の薬剤揮散容器の好ましい一実施態様においては、前記台座部には、前記台座部の上面から突き出て前記薬剤を貫通する保持支柱が設けられており、前記保持支柱は、下端が開口した筒状体からなり、前記連通部は、前記保持支柱に設けられていることを特徴としている。この実施態様によれば、蓋部を台座部上に液密に固定した状態で、蓋部の収納空間の内外を連通することができる。   In a preferred embodiment of the drug volatilization container having the above-described configuration, the pedestal portion is provided with a holding column that protrudes from the upper surface of the pedestal unit and penetrates the drug, and the lower end of the holding column is opened. It consists of a cylindrical body, The said communication part is provided in the said holding support | pillar, It is characterized by the above-mentioned. According to this embodiment, the inside and outside of the storage space of the lid can be communicated with the lid being fixed in a liquid-tight manner on the pedestal.

この実施態様において、前記リング状部材は、前記台座部との係合時に、前記リング状部材の下端部が前記台座部の下端部よりも下方に突き出ており、前記リング状部材には、前記連通部と通気可能な通気孔が設けられていることが好ましい。この実施態様によれば、台座部とリング状部材との係合時には、リング状部材の下端部が台座部の下端部よりも下方に突き出るため、薬剤揮散容器を台などの上に置いた際に、台座部が宙に浮き、連通部が閉じられるのが防止されるうえ、通気孔を介してリング状部材の内外が通気することで、蓋部の内外の空気の連通が良好になる。   In this embodiment, when the ring-shaped member is engaged with the pedestal portion, the lower end portion of the ring-shaped member protrudes below the lower end portion of the pedestal portion, and the ring-shaped member includes It is preferable that a vent hole that can ventilate the communication portion is provided. According to this embodiment, when the base portion and the ring-shaped member are engaged, the lower end portion of the ring-shaped member protrudes downward from the lower end portion of the base portion. In addition, the pedestal portion is prevented from floating in the air and the communication portion is prevented from being closed, and the inside and outside of the ring-shaped member are ventilated through the vent hole, so that the communication between the inside and outside of the lid portion is improved.

この実施態様において、前記台座部には、前記台座部の上面から突き出て前記蓋部の内壁面と対向する環状の堰部が設けられていることが好ましい。この実施態様によれば、台座部上に蓋部を載置する際に、堰部により蓋部を最適な位置に位置決めすることができる。また、リング状部材と台座部との係合により蓋部を台座部上に固定する際に、蓋部が紙製や薄手のプラスチック製などの柔らかい材質であると、リング状部材の締め付けにより、蓋部が内側に押し込まれる恐れがある。このとき、堰部がストッパーとして機能して蓋部が内側に押し込まれるのを防ぐことで、蓋部の形状を保持できる。また、このとき、蓋部の内周面が堰部の外周面と当接することで蓋部内をより良好に密閉することができる。   In this embodiment, it is preferable that the pedestal portion is provided with an annular weir portion that protrudes from the upper surface of the pedestal portion and faces the inner wall surface of the lid portion. According to this embodiment, when placing the lid portion on the pedestal portion, the lid portion can be positioned at an optimum position by the dam portion. Further, when the lid portion is fixed on the pedestal portion by engagement between the ring-shaped member and the pedestal portion, if the lid portion is a soft material such as paper or thin plastic, the ring-shaped member is tightened, The lid may be pushed inward. At this time, the shape of the lid can be maintained by preventing the weir from functioning as a stopper and pushing the lid inward. Moreover, at this time, the inside of the lid can be better sealed because the inner peripheral surface of the lid comes into contact with the outer peripheral surface of the weir.

また、他の実施態様においては、前記連通部は、前記コンタクトリングに設けられていることを特徴としている。この実施態様によれば、簡単な構造で蓋部の収納空間の内外を連通する連通部を設けることができる。   In another embodiment, the communication portion is provided in the contact ring. According to this embodiment, it is possible to provide the communication portion that communicates the inside and outside of the storage space of the lid portion with a simple structure.

他の実施態様において、前記台座部の上面には、前記薬剤の周囲に、前記薬剤から吐き出されて遊離した水分を貯留するための貯水溝が1つまたは複数設けられていることが好ましい。上記構成の薬剤揮散容器において、薬剤がゲル状の場合には、時間の経過と共に含有する水分が薬剤から吐き出されて遊離するが、この実施態様によれば、この遊離した水分を貯水溝に貯留することで、水分が薬剤揮散容器から漏れ出すことを防止できる。   In another embodiment, the upper surface of the pedestal part is preferably provided with one or a plurality of water storage grooves around the medicine for storing moisture discharged from the medicine and released. In the drug volatilization container having the above-described configuration, when the drug is in a gel form, the contained water is discharged and released from the drug as time passes. According to this embodiment, the released moisture is stored in the water storage groove. By doing, it can prevent that a water | moisture content leaks out from a chemical volatilization container.

他の実施態様においても、前記台座部の上面には、上面から突き出て前記蓋部の内壁面と対向する環状の堰部を設けることができ、さらに、前記1つまたは複数の貯水溝は、前記コンタクトリングと前記堰部との間に設けられていることが好ましい。この実施態様によれば、コンタクトリングと堰部との間で水分を保持することができ、水分がコンタクトリングを超えて滲み出すことを防止できるので、水分が薬剤揮散容器から漏れ出すことを良好に防止できる。   In another embodiment, the upper surface of the pedestal portion can be provided with an annular weir portion that protrudes from the upper surface and faces the inner wall surface of the lid portion, and the one or more water storage grooves are It is preferable that it is provided between the contact ring and the weir portion. According to this embodiment, moisture can be retained between the contact ring and the weir part, and moisture can be prevented from seeping out beyond the contact ring, so that moisture can be leaked from the chemical volatilization container. Can be prevented.

他の実施態様において、前記台座部は、前記フランジ部を囲繞する周壁部を有し、前記周壁部の下端部は、前記台座部の下面よりも突き出ており、かつ、前記リング状部材の係合時に前記リング状部材の下端部よりも下方に突き出ていることが好ましい。この実施態様によれば、台座部とリング状部材との係合時には台座部の周壁部の下端部がリング状部材の下端部よりも下方に突き出る。そのため、例えば薬剤揮散容器が誤って台上などに落下した場合においては、台座部が主に台などから衝撃を受ける。ここで、リング状部材の下端部が台座部の周壁部の下端部よりも下方に突き出ることで、落下時にリング状部材が主に台などから衝撃を受けると、リング状部材には台座部との係合が外れる上向きの力が作用するため、衝撃の度合いが大きいと、落下時の衝撃によりリング状部材が台座部から外れる恐れがあるが、この実施態様では、落下時の衝撃を主に台座部に作用させることで、リング状部材が台座部から外れることを防止できる。   In another embodiment, the pedestal portion has a peripheral wall portion surrounding the flange portion, a lower end portion of the peripheral wall portion protrudes from a lower surface of the pedestal portion, and the ring-shaped member is engaged. It is preferable to protrude downward from the lower end of the ring-shaped member at the time. According to this embodiment, when the pedestal portion and the ring-shaped member are engaged, the lower end portion of the peripheral wall portion of the pedestal portion protrudes downward from the lower end portion of the ring-shaped member. Therefore, for example, when the chemical volatilization container is accidentally dropped onto a table or the like, the pedestal part receives an impact mainly from the table or the like. Here, when the ring-shaped member receives an impact mainly from the table or the like when falling, the lower end of the ring-shaped member protrudes below the lower end of the peripheral wall of the pedestal, and the ring-shaped member Since an upward force is applied to disengage the ring, if the degree of impact is large, the ring-shaped member may be detached from the pedestal due to the impact at the time of dropping, but in this embodiment, the impact at the time of dropping is mainly used. By making it act on a base part, it can prevent that a ring-shaped member remove | deviates from a base part.

本発明の上記したいずれの実施態様においても、前記台座部および前記リング状部材は、雌ネジ部および雄ネジ部の螺合により互いに係合され、前記台座部の下面には、前記台座部および前記リング状部材が係合する回転方向に向けて深く傾斜する溝が1つまたは複数設けられていることが好ましい。この実施態様によれば、リング状部材に対して台座部を回転させて両者を係合させる場合には、溝に指の爪などを引っ掛けて台座部を回転させれば、両者を容易に係合させることができる。一方で、両者の係合を外すためにリング状部材に対して台座部を上記とは反対方向に回転させる場合には、溝に指の爪などを引っ掛けても、爪などが溝上を滑って台座部を回転させることができず、両者の係合を外すことが困難となる。このように、この実施態様においては、リング状部材から台座部を取り外すことを防止できる。   In any of the above-described embodiments of the present invention, the pedestal portion and the ring-shaped member are engaged with each other by screwing of the female screw portion and the male screw portion, and the lower surface of the pedestal portion has the pedestal portion and It is preferable that one or a plurality of grooves that are deeply inclined in the rotation direction with which the ring-shaped member is engaged are provided. According to this embodiment, when the pedestal portion is rotated with respect to the ring-shaped member to engage the two, if the pedestal portion is rotated by hooking a fingernail or the like in the groove, the two portions can be easily engaged. Can be combined. On the other hand, when the pedestal is rotated in the opposite direction to the ring-shaped member in order to disengage the two members, even if a fingernail is caught in the groove, the nail will slip on the groove. The pedestal cannot be rotated and it becomes difficult to disengage the two. Thus, in this embodiment, it can prevent removing a base part from a ring-shaped member.

本発明の薬剤揮散容器によれば、台座部と蓋部とを確実に固定することができるので、誤って薬剤揮散容器が倒れたりした場合でも、台座部と蓋部との固定が外れることがなく、蓋部内に収納された薬剤から吐き出されて遊離する水分が漏れ出すことを防止できる。また、フランジ部が台座部の上面とリング状部材とで挟持されることで、蓋部内を良好に密閉することができる。また、台座部に連通部を設ければ、使用前に蓋部内が減圧して蓋部の一部が凹むことを防止できる。また、蓋部を台座部上に固定する際、蓋部のフランジ部を、パッキンを介して台座部の上面とリング状部材とで挟持すれば、蓋部内をほぼ完全に密閉することができる。また、この際、台座部の薬剤を保持する保持支柱に連通部を設ければ、蓋部内をほぼ完全な密閉状態としたうえで、連通部を介して蓋部の収納空間の内外を空気が流通可能となる。   According to the chemical volatilization container of the present invention, since the pedestal part and the lid part can be securely fixed, even if the chemical volatilization container falls down accidentally, the fixation between the pedestal part and the lid part may be released. In addition, it is possible to prevent leakage of moisture discharged and discharged from the medicine stored in the lid. Moreover, the inside of a cover part can be favorably sealed because a flange part is clamped by the upper surface of a base part, and a ring-shaped member. Moreover, if a communicating part is provided in a base part, it can prevent that the inside of a cover part depressurizes before use and a part of cover part is dented. Further, when the lid portion is fixed on the pedestal portion, if the flange portion of the lid portion is sandwiched between the upper surface of the pedestal portion and the ring-shaped member via the packing, the inside of the lid portion can be almost completely sealed. Further, at this time, if a communication portion is provided in the holding column for holding the medicine on the pedestal portion, the inside of the lid portion is made to be in a completely perfect sealed state, and air is passed through the inside and outside of the storage space of the lid portion via the communication portion. Distribution is possible.

本発明の第1実施形態に係る薬剤揮散容器の縦断面図である。It is a longitudinal cross-sectional view of the chemical volatilization container which concerns on 1st Embodiment of this invention. 図1の薬剤揮散容器の台座部およびリング状部材の係合部を拡大した拡大断面図である。It is the expanded sectional view which expanded the base part of the chemical volatilization container of FIG. 1, and the engaging part of a ring-shaped member. 蓋部の正面図である。It is a front view of a cover part. 台座部(鍔部材を除く)の斜め上方から見た斜視図である。It is the perspective view seen from diagonally upward of the base part (except for a collar member). 台座部(鍔部材を除く)の斜め下方から見た斜視図である。It is the perspective view seen from the slanting lower part of the base part (except for a collar member). 台座部(鍔部材を除く)の側面図である。It is a side view of a base part (except a collar member). 図1の台座部(鍔部材を除く)の平面図である。It is a top view of the base part (except a collar member) of FIG. 図1の台座部(鍔部材を除く)の底面図である。FIG. 2 is a bottom view of the pedestal portion (excluding the flange member) of FIG. 1. 図7のB−B線に沿う断面図である。It is sectional drawing which follows the BB line of FIG. 図9の一部分を拡大して示す拡大断面図である。It is an expanded sectional view which expands and shows a part of FIG. 図7のA−A線に沿う断面図である。It is sectional drawing which follows the AA line of FIG. 鍔部材の斜め上方から見た斜視図である。It is the perspective view seen from diagonally upward of the collar member. 鍔部材の斜め下方から見た斜視図である。It is the perspective view seen from the slanting lower part of the collar member. 鍔部材の平面図である。It is a top view of a collar member. 鍔部材の底面図である。It is a bottom view of a collar member. 鍔部材の側面図である。It is a side view of a collar member. 図14のC−C線に沿う断面図である。It is sectional drawing which follows the CC line | wire of FIG. リング状部材の斜め上方から見た斜視図である。It is the perspective view seen from diagonally upward of the ring-shaped member. リング状部材の斜め下方から見た斜視図である。It is the perspective view seen from the slanting lower part of the ring-shaped member. リング状部材の平面図である。It is a top view of a ring-shaped member. リング状部材の底面図である。It is a bottom view of a ring-shaped member. リング状部材の側面図である。It is a side view of a ring-shaped member. 図20のD−D線に沿う断面図である。It is sectional drawing which follows the DD line | wire of FIG. 図23の一部分を拡大して示す拡大断面図である。It is an expanded sectional view which expands and shows a part of FIG. 本発明の第2実施形態に係る薬剤揮散容器の縦断面図である。It is a longitudinal cross-sectional view of the chemical volatilization container which concerns on 2nd Embodiment of this invention. 図25の台座部(鍔部材を除く)の斜視図である。FIG. 26 is a perspective view of the pedestal portion (excluding the flange member) of FIG. 25. 図25の台座部(鍔部材を除く)の側面図である。FIG. 26 is a side view of the pedestal portion (excluding the flange member) of FIG. 25. 図25の台座部(鍔部材を除く)の平面図である。FIG. 26 is a plan view of the pedestal portion (excluding the flange member) of FIG. 25. 図25の台座部(鍔部材を除く)の底面図である。FIG. 26 is a bottom view of the pedestal portion (excluding the flange member) of FIG. 25. 図25の鍔部材および保持支柱の一部の斜め上方から見た斜視図である。It is the perspective view seen from diagonally upper part of the collar member of FIG. (a)は従来例の薬剤揮散容器の斜視図であり、(b)は(a)の縦断面図である。(A) is a perspective view of the chemical | medical agent volatilization container of a prior art example, (b) is a longitudinal cross-sectional view of (a).

以下、本発明の実施形態について、添付図面を参照して説明する。   Embodiments of the present invention will be described below with reference to the accompanying drawings.

(実施形態1)
図1は、本発明の第1実施形態に係る薬剤揮散容器1の縦断面図を示している。また、図2は、図1の薬剤揮散容器1の台座部3とリング状部材5との係合部6を拡大した拡大断面図である。第1実施形態の薬剤揮散容器1は、固形または半固形の薬剤2と、薬剤2を載置する台座部3と、台座部3上の薬剤2を覆う蓋部4と、台座部3上に蓋部4を固定するリング状部材5とを備えている。
(Embodiment 1)
FIG. 1: has shown the longitudinal cross-sectional view of the chemical volatilization container 1 which concerns on 1st Embodiment of this invention. FIG. 2 is an enlarged cross-sectional view in which the engaging portion 6 between the pedestal portion 3 and the ring-shaped member 5 of the chemical volatilization container 1 in FIG. 1 is enlarged. The drug volatilization container 1 according to the first embodiment includes a solid or semi-solid drug 2, a pedestal 3 on which the drug 2 is placed, a lid 4 that covers the drug 2 on the pedestal 3, and a pedestal 3. And a ring-shaped member 5 for fixing the lid 4.

薬剤2は、揮散性(薬効徐放性)を有し、空気中に揮散することで消臭、芳香などの薬効を奏するゲル状薬剤である。ゲル状薬剤は、例えば、水に、ゲル化剤、界面活性剤、揮散性物質、消臭・芳香成分などの薬剤成分を溶解または分散させたゾルをゲル化(固化または半固化)したものである。消臭・芳香成分としては、任意のものを採用することができ、例えば、天然香料や合成香料、両性界面活性剤系消臭剤、脂肪酸塩系消臭剤などを使用することができる。   The chemical | medical agent 2 is a gel-like chemical | medical agent which has volatility (medicine effect sustained release), and shows medicinal effects, such as a deodorizing and a fragrance, by volatilizing in air. A gel-like drug is obtained by gelling (solidifying or semi-solidifying) a sol in which a drug component such as a gelling agent, a surfactant, a volatile substance, and a deodorant / fragrance component is dissolved or dispersed in water. is there. Arbitrary things can be employ | adopted as a deodorizing and aroma component, For example, a natural fragrance | flavor, a synthetic | combination fragrance | flavor, an amphoteric surfactant type | system | group deodorant, a fatty-acid salt type | system | group deodorant etc. can be used.

蓋部4は、図1および図3に示すように、上端が閉じられ下端が開口したカップ状のものであり、内部に薬剤2を収納可能な収納空間40を有している。蓋部4の下端開口の周縁には、外方に延出するフランジ部45が一体に設けられている。蓋部4の周壁41には、収納空間40内の薬剤2を外部に揮散させるための揮散孔42が少なくとも1つ(例えば3つ)設けられている。揮散孔42は、薬剤揮散容器1の使用前は、カバー部材43によって塞がれている。カバー部材43は、蓋部4の周壁41に所定形状(例えばU字状、コ字状、円弧状など)のミシン目44を形成することで周壁41に設けられ、ミシン目44の両端を基部とし、ミシン目44を破断してカバー部材43を周壁41に対して回動させることで、揮散孔42が形成される。なお、各揮散孔42は、蓋部4内に収納される薬剤2よりも上方位置に設けられるのが好ましい。また、蓋部4の大きさとしては、収納される薬剤2の外周面と内壁面との間に隙間が設けられるような大きさとするのが好ましい。これにより、揮散面積が拡大し、揮散した薬剤2が蓋部4の内壁面との間を通って上昇し、各揮散孔42から外部に放出されるので、薬剤2の放出を円滑に行うことができる。上記した構成の蓋部4の材質は特に限定されるものではないが、容易に使い捨てできる点で、紙製(紙カップ)や薄手のプラスチック製(クリアカップ)であることが好ましい。   As shown in FIGS. 1 and 3, the lid portion 4 is a cup-shaped member having an upper end closed and a lower end opened, and has a storage space 40 in which the medicine 2 can be stored. A flange portion 45 extending outward is integrally provided at the periphery of the lower end opening of the lid portion 4. The peripheral wall 41 of the lid portion 4 is provided with at least one (for example, three) volatilization holes 42 for volatilizing the medicine 2 in the storage space 40 to the outside. The volatilization hole 42 is closed by a cover member 43 before the chemical volatilization container 1 is used. The cover member 43 is provided on the peripheral wall 41 by forming a perforation 44 having a predetermined shape (for example, a U shape, a U shape, an arc shape, etc.) on the peripheral wall 41 of the lid portion 4. The volatilization hole 42 is formed by breaking the perforation 44 and rotating the cover member 43 with respect to the peripheral wall 41. In addition, it is preferable that each volatilization hole 42 is provided in the upper position rather than the chemical | medical agent 2 accommodated in the cover part 4. FIG. In addition, the size of the lid portion 4 is preferably set such that a gap is provided between the outer peripheral surface and the inner wall surface of the medicine 2 to be stored. Thereby, the volatilization area is expanded, and the volatilized drug 2 rises between the inner wall surface of the lid part 4 and is released to the outside from each volatilization hole 42. Therefore, the drug 2 is smoothly released. Can do. The material of the lid 4 having the above-described configuration is not particularly limited, but is preferably made of paper (paper cup) or thin plastic (clear cup) in that it can be easily disposed of.

台座部3は、図1、図2および図4〜図11に示すように、合成樹脂製であって、平面視円形状に形成されており、底壁部30と、底壁部30の周縁から立ち上がる環状の周壁部31とを備えている。周壁部31の内面の上部には、後述するリング状部材5の雄ネジ部52と螺合する雌ネジ部32が設けられている(図1を参照)。この雄ネジ部52および雌ネジ部32は、台座部3の周縁とリング状部材5とを係合させる係合部6を構成している。周壁部31の下端部は、台座部3の下面よりも下方に突き出ている。   As shown in FIGS. 1, 2, and 4 to 11, the pedestal portion 3 is made of synthetic resin and is formed in a circular shape in plan view, and includes a bottom wall portion 30 and a peripheral edge of the bottom wall portion 30. And an annular peripheral wall portion 31 that rises from the top. A female screw portion 32 that is screwed with a male screw portion 52 of the ring-shaped member 5 described later is provided on the upper part of the inner surface of the peripheral wall portion 31 (see FIG. 1). The male screw portion 52 and the female screw portion 32 constitute an engaging portion 6 that engages the peripheral edge of the pedestal portion 3 with the ring-shaped member 5. The lower end portion of the peripheral wall portion 31 protrudes downward from the lower surface of the pedestal portion 3.

底壁部30の中央部には、底壁部30上に載置された薬剤2内に嵌合して薬剤2を底壁部30上に保持するための保持支柱33が設けられている。保持支柱33は、本実施形態では、底壁部30の上面から突き出る複数(図示例では4つ)の板状の保持板33Aからなり、各保持板33Aが底壁部30の中央位置を中心に放射状に延びることで、薬剤2が周方向に回転するのが規制されている。また、保持支柱33の上部には、円盤状の鍔部材34が取り外し可能に設けられており、鍔部材34により薬剤2が上下方向に移動するのが規制されている。   At the center of the bottom wall portion 30, a holding column 33 is provided for fitting in the medicine 2 placed on the bottom wall portion 30 and holding the medicine 2 on the bottom wall portion 30. In this embodiment, the holding column 33 is composed of a plurality (four in the illustrated example) of plate-like holding plates 33A protruding from the upper surface of the bottom wall portion 30, and each holding plate 33A is centered on the center position of the bottom wall portion 30. The medicine 2 is restricted from rotating in the circumferential direction by extending radially. In addition, a disc-shaped scissors member 34 is detachably provided on the upper portion of the holding column 33, and the scissors member 34 is restricted from moving in the vertical direction.

鍔部材34は、図12〜図17に示すように、円盤部34Aと、中央に開口を有し円盤部34Aの下面から突き出る平面視円状の凹部34Bと、上記開口の周縁に設けられ凹部34Bの上面から突き出る円筒状部34Cとを備えている。各保持板33Aの上部には、コ字状の溝33Bが形成されることで係止片33Cが設けられている。上記開口から各保持板33Aの上部を鍔部材34に嵌め込み、各保持板33Aのコ字状の溝33Bに凹部34Bおよび円筒状部34Cを嵌合させて係止片33Cを円筒状部34Cの上端に係止させることで、鍔部材34が保持支柱33に取り付けられる。また、この係合は保持支柱33の各保持板33Aの弾性変形に基づいて行なわれるので、鍔部材34を引っ張って各保持板33Aとの係合を解くことで、鍔部材34を取り外すことができる。   As shown in FIGS. 12 to 17, the eaves member 34 includes a disk portion 34 </ b> A, a concave portion 34 </ b> B having a circular opening in the center and protruding from the lower surface of the disk portion 34 </ b> A, and a concave portion provided at the periphery of the opening. And a cylindrical portion 34C protruding from the upper surface of 34B. A locking piece 33C is provided on the upper portion of each holding plate 33A by forming a U-shaped groove 33B. The upper portion of each holding plate 33A is fitted into the eave member 34 from the opening, and the concave portion 34B and the cylindrical portion 34C are fitted into the U-shaped groove 33B of each holding plate 33A so that the locking piece 33C is attached to the cylindrical portion 34C. The hook member 34 is attached to the holding column 33 by being locked to the upper end. Further, since this engagement is performed based on the elastic deformation of each holding plate 33A of the holding column 33, the hook member 34 can be removed by pulling the hook member 34 to release the engagement with each holding plate 33A. it can.

図1、図2および図4〜図11に戻って、底壁部30の上面には、載置される薬剤2の直径よりも僅かに大きい内径を有する環状の環状壁35が、底壁部30の上面から突き出るようにして設けられている。また、環状壁35の周囲には、環状壁35よりも高さが低く、底壁部30上に載置された蓋部4の内壁面と対向する環状の堰部36が、底壁部30の上面から突き出るようにして設けられている。さらに、堰部36の周囲には、堰部36よりも高さが低い環状のコンタクトリング37が、底壁部30の上面から突き出るようにして設けられている。   Returning to FIGS. 1, 2, and 4 to 11, an annular annular wall 35 having an inner diameter slightly larger than the diameter of the medicine 2 to be placed is provided on the upper surface of the bottom wall portion 30. It is provided so as to protrude from the upper surface of 30. In addition, an annular weir portion 36 that is lower than the annular wall 35 and faces the inner wall surface of the lid portion 4 placed on the bottom wall portion 30 is provided around the annular wall 35. It is provided so as to protrude from the upper surface of. Further, an annular contact ring 37 having a lower height than the dam portion 36 is provided around the dam portion 36 so as to protrude from the upper surface of the bottom wall portion 30.

堰部36は、蓋部4の下端開口の直径よりも僅かに小さい外径を有しており、蓋部4を底壁部30上に載置する際に、蓋部4を最適な位置に位置させる位置決めとして機能する。また、後述するように、蓋部4を底壁部30上に載置した状態で、リング状部材5と台座部3との係合により蓋部4を台座部3に固定する際に、蓋部4が紙製や薄手のプラスチック製などの柔らかい材質であると、リング状部材5の締め付けにより、蓋部4の周壁41の下部が内側に押し込まれる恐れがある。このとき、堰部36がストッパーとして機能して蓋部4の周壁41の下部が内側に押し込まれるのを防ぐことで、蓋部4の周壁41の形状を保持できる。また、このとき、蓋部4の内壁面が堰部36の外周面と当接することで蓋部4の収納空間40内を良好に密閉することができる。   The weir portion 36 has an outer diameter slightly smaller than the diameter of the lower end opening of the lid portion 4, and when the lid portion 4 is placed on the bottom wall portion 30, the lid portion 4 is placed in an optimal position. It functions as positioning to position. As will be described later, when the lid 4 is fixed to the pedestal 3 by the engagement of the ring-shaped member 5 and the pedestal 3 with the lid 4 placed on the bottom wall 30, the lid If the portion 4 is made of a soft material such as paper or thin plastic, the lower portion of the peripheral wall 41 of the lid portion 4 may be pushed inward by tightening the ring-shaped member 5. At this time, the shape of the peripheral wall 41 of the cover part 4 can be maintained by preventing the lower part of the peripheral wall 41 of the cover part 4 from being pushed inward by the dam part 36 functioning as a stopper. Further, at this time, the inner wall surface of the lid portion 4 abuts on the outer peripheral surface of the dam portion 36, so that the inside of the storage space 40 of the lid portion 4 can be satisfactorily sealed.

コンタクトリング37は、底壁部30上に載置される蓋部4のフランジ部45と対向する位置に設けられており、蓋部4が底壁部30上に載置される際、フランジ部45の下面がコンタクトリング37の上面と当接する。後述するように、リング状部材5は、台座部3との係合時に蓋部4のフランジ部45と対向する円環部50を備えており(図1を参照)、台座部3のコンタクトリング37とリング状部材5の円環部50とでフランジ部45を上下から挟持することで、蓋部4が確実に台座部3に固定される。これにより、使用時または使用前に薬剤揮散容器1が倒れたりした場合でも、台座部3と蓋部4との固定が外れることが防止される。また、フランジ部45が台座部3のコンタクトリング37とリング状部材5の円環部50とで挟持されることで、蓋部4の収納空間40内を液密に密閉することができる。   The contact ring 37 is provided at a position facing the flange portion 45 of the lid portion 4 placed on the bottom wall portion 30, and when the lid portion 4 is placed on the bottom wall portion 30, the flange portion The lower surface of 45 abuts on the upper surface of the contact ring 37. As will be described later, the ring-shaped member 5 includes an annular portion 50 that faces the flange portion 45 of the lid portion 4 when engaged with the pedestal portion 3 (see FIG. 1), and the contact ring of the pedestal portion 3. 37 and the annular portion 50 of the ring-shaped member 5 sandwich the flange portion 45 from above and below, so that the lid portion 4 is securely fixed to the pedestal portion 3. Thereby, even when the chemical volatilization container 1 falls down at the time of use or before use, it is prevented that fixation of the base part 3 and the cover part 4 comes off. Further, the flange portion 45 is sandwiched between the contact ring 37 of the pedestal portion 3 and the annular portion 50 of the ring-shaped member 5, so that the inside of the storage space 40 of the lid portion 4 can be hermetically sealed.

台座部3には、蓋部4の収納空間40の内外を連通する連通部38が設けられている。蓋部4の収納空間40内が完全に密閉されていると、薬剤揮散容器1の使用前に収納空間40内の酸素が消費されることで、収納空間40内が減圧し、その結果、蓋部4の周壁41の一部が凹むという問題が生じる。本実施形態では、連通部38を介して蓋部4の収納空間40の内外の空気の流通が可能になっているので、薬剤揮散容器1の使用前に収納空間40内が減圧することを防止でき、よって、蓋部4の周壁41が凹むことを防止できる。   The pedestal portion 3 is provided with a communication portion 38 that communicates the inside and outside of the storage space 40 of the lid portion 4. When the inside of the storage space 40 of the lid part 4 is completely sealed, oxygen in the storage space 40 is consumed before the chemical volatilization container 1 is used, so that the inside of the storage space 40 is depressurized. There arises a problem that a part of the peripheral wall 41 of the portion 4 is recessed. In the present embodiment, since the air inside and outside the storage space 40 of the lid 4 can be circulated through the communication portion 38, the inside of the storage space 40 is prevented from being depressurized before the chemical volatilization container 1 is used. Therefore, it can prevent that the surrounding wall 41 of the cover part 4 is dented.

本実施形態では、堰部36の外周面に上端から下端まで上下方向に延びる第1の溝部38Aが形成されているともに、底壁部30の上面に第1の溝部38Aと連続し、底壁部30の上面を径方向にコンタクトリング37を貫通して蓋部4外の周壁部31まで延びる第2の溝部38Bが形成されている。第1の溝部38Aは、堰部36の外周面と蓋部4の内壁面との間に隙間を形成し、第2の溝部38Bは、底壁部30の上面(コンタクトリング37)と蓋部4のフランジ部45との間に隙間を形成しており、第1、第2の溝部38A,38Bで蓋部4の収納空間40の内外を連通している。   In the present embodiment, the first groove portion 38A extending in the vertical direction from the upper end to the lower end is formed on the outer peripheral surface of the dam portion 36, and is continuous with the first groove portion 38A on the upper surface of the bottom wall portion 30. A second groove 38 </ b> B extending through the contact ring 37 in the radial direction on the upper surface of the portion 30 to the peripheral wall portion 31 outside the lid portion 4 is formed. The first groove portion 38A forms a gap between the outer peripheral surface of the dam portion 36 and the inner wall surface of the lid portion 4, and the second groove portion 38B is formed on the upper surface (contact ring 37) of the bottom wall portion 30 and the lid portion. A gap is formed between the first and second flange portions 45, and the first and second groove portions 38A and 38B communicate the inside and outside of the storage space 40 of the lid portion 4.

連通部38の大きさや数は特に限定されず、台座部3に複数設けてもよい。また、連通部38の形状は本実施形態のように溝部である必要はない。例えば、第2の溝部38Bに代えてコンタクトリング37に貫通孔を形成することによっても、上記貫通孔および第1の溝部38Aにより蓋部4の収納空間40の内外を連通させることができる。また、底壁部30の上面に堰部36を設けない場合や、堰部36の外周面と蓋部4の内壁面とが必ずしも当接しない場合には、第1の溝部38Aを設ける必要はなく、第2の溝部38Bもしくはコンタクトリング37に形成する上記貫通孔だけで、蓋部4の収納空間40の内外を連通させることができる。   The size and number of the communication portions 38 are not particularly limited, and a plurality of communication portions 38 may be provided on the pedestal portion 3. Moreover, the shape of the communication part 38 does not need to be a groove part like this embodiment. For example, by forming a through hole in the contact ring 37 instead of the second groove 38B, the inside and outside of the storage space 40 of the lid 4 can be communicated with each other by the through hole and the first groove 38A. Further, when the dam portion 36 is not provided on the upper surface of the bottom wall portion 30 or when the outer peripheral surface of the dam portion 36 and the inner wall surface of the lid portion 4 are not necessarily in contact with each other, it is necessary to provide the first groove portion 38A. In addition, the inside and outside of the storage space 40 of the lid portion 4 can be communicated with each other only by the through hole formed in the second groove portion 38B or the contact ring 37.

台座部3の底壁部30の上面には、薬剤2の周囲に1つまたは複数の貯水溝39が形成されている。本実施形態では、コンタクトリング37と堰部36との間に、複数の貯水溝39が周方向に沿って所定間隔をあけて並設されており、各貯水溝39は、堰部36の下端から底壁部30の上面を放射状にコンタクトリング37の手前まで延びている。この貯水溝39は、薬剤2から発散された水分を貯留するためのものである。薬剤2がゲル状の場合には、時間の経過とともにゲル状薬剤2が保持する水分の一部が吐き出される。吐き出された水分は、蓋部4の内壁面に付着し、内壁面を流下した後、堰部36の内外に分散されるが、堰部36の外側に分散された一部の水分は、堰部36の外周面に形成された複数の縦溝36Aを介してコンタクトリング37との間の底壁部30上に排出される。このとき、本実施形態では、底壁部30の上面に、各縦溝36Aに対応するように貯水溝39が形成されているので、排出された水分が各貯水溝39に貯留される。これにより、排出された水分がコンタクトリング37を越えて滲み出すのが防止されるため、薬剤揮散容器1の外側へ水分が漏れ出すのを防止することができる。なお、貯水溝39の形状や大きさ、数は特に限定されず、種々の形状や大きさ、数に設定することができる。   One or a plurality of water storage grooves 39 are formed around the medicine 2 on the upper surface of the bottom wall portion 30 of the pedestal portion 3. In the present embodiment, a plurality of water storage grooves 39 are juxtaposed at predetermined intervals along the circumferential direction between the contact ring 37 and the weir part 36, and each water storage groove 39 has a lower end of the weir part 36. The upper surface of the bottom wall portion 30 extends radially before the contact ring 37. The water storage groove 39 is for storing the water emitted from the medicine 2. When the medicine 2 is in a gel form, a part of the water retained by the gel medicine 2 is discharged over time. The discharged water adheres to the inner wall surface of the lid portion 4 and flows down the inner wall surface, and then is dispersed inside and outside the weir portion 36. However, a part of the moisture dispersed outside the weir portion 36 is It is discharged onto the bottom wall portion 30 between the contact ring 37 via a plurality of vertical grooves 36A formed on the outer peripheral surface of the portion 36. At this time, in the present embodiment, since the water storage grooves 39 are formed on the upper surface of the bottom wall portion 30 so as to correspond to the vertical grooves 36 </ b> A, the discharged water is stored in the water storage grooves 39. Thereby, since the discharged | emitted water | moisture content is prevented from seeping out beyond the contact ring 37, it can prevent that a water | moisture content leaks to the outer side of the chemical volatilization container 1. FIG. The shape, size, and number of the water storage grooves 39 are not particularly limited, and can be set to various shapes, sizes, and numbers.

台座部3の下面には、雄ネジ部52および雌ネジ部32の螺合により、台座部3およびリング状部材5が係合する回転方向に向けて深く入り込む溝60が少なくとも1つ(例えば3つ)設けられている。このような構成の溝60は、台座部3およびリング状部材5が係合する回転方向に向けて深く傾斜する傾斜面61と、傾斜面61の先端に位置する鉛直面62とを備えており、リング状部材5に対して台座部3を回転させて両者を係合させる場合には、台座部3の鉛直面62に指の爪などを引っ掛けて台座部3を回転させれば、両者を容易に係合させることができる。一方で、両者の係合を外すためにリング状部材5に対して台座部3を上記とは反対方向に回転させる場合には、台座部3の傾斜面61に指の爪などを引っ掛けても、爪などが傾斜面61上を滑って台座部3を回転させることができないため、両者の係合を外すことが困難になっている。このように本実施形態では、台座部3からリング状部材5が容易に取り外されることが防止されている。   The lower surface of the pedestal portion 3 has at least one groove 60 (for example, 3) that penetrates deeply in the rotation direction in which the pedestal portion 3 and the ring-shaped member 5 are engaged by screwing the male screw portion 52 and the female screw portion 32. One) is provided. The groove 60 having such a configuration includes an inclined surface 61 that is deeply inclined in the rotational direction in which the pedestal 3 and the ring-shaped member 5 are engaged, and a vertical surface 62 that is positioned at the tip of the inclined surface 61. When the pedestal part 3 is rotated with respect to the ring-shaped member 5 and both are engaged, if the fingernail or the like is hooked on the vertical surface 62 of the pedestal part 3 to rotate the pedestal part 3, It can be easily engaged. On the other hand, when the pedestal portion 3 is rotated relative to the ring-shaped member 5 in the direction opposite to the above in order to disengage the both, a fingernail or the like may be hooked on the inclined surface 61 of the pedestal portion 3. Since the claw or the like cannot slide on the inclined surface 61 and rotate the pedestal portion 3, it is difficult to disengage the two. Thus, in this embodiment, the ring-shaped member 5 is prevented from being easily removed from the pedestal portion 3.

次に、リング状部材5は、図1、図2および図18〜図24に示すように、合成樹脂製であって、平面視円形状に形成されており、環状の円環部50と、円環部50を囲繞するように設けられ円環部50に一体に設けられた環状の囲繞部51とを備えている。円環部50の外周面には、台座部3(周壁部31)の内周面に設けられた雌ネジ部32と螺合する雄ネジ部52が設けられており、台座部3とリング状部材5との係合時、台座部3の周壁部31はリング状部材5の円環部50と囲繞部51との間に位置している。円環部50の下部内周面には、上下方向に延びる複数のリブ53が周方向に所定の間隔をあけて設けられており、円環部50の下部部分を補強している。円環部50は、リング状部材5と台座部3との係合時に蓋部4のフランジ部45と対向し、台座部3のコンタクトリング37とでフランジ部45を上下から挟持する。   Next, as shown in FIGS. 1, 2, and 18 to 24, the ring-shaped member 5 is made of a synthetic resin and is formed in a circular shape in a plan view. An annular surrounding portion 51 is provided so as to surround the annular portion 50 and is provided integrally with the annular portion 50. On the outer peripheral surface of the annular portion 50, a male screw portion 52 that is screwed with the female screw portion 32 provided on the inner peripheral surface of the pedestal portion 3 (peripheral wall portion 31) is provided. At the time of engagement with the member 5, the peripheral wall portion 31 of the pedestal portion 3 is located between the annular portion 50 and the surrounding portion 51 of the ring-shaped member 5. A plurality of ribs 53 extending in the vertical direction are provided on the lower inner peripheral surface of the annular portion 50 at a predetermined interval in the circumferential direction, thereby reinforcing the lower portion of the annular portion 50. The annular portion 50 faces the flange portion 45 of the lid portion 4 when the ring-shaped member 5 and the pedestal portion 3 are engaged, and sandwiches the flange portion 45 from above and below with the contact ring 37 of the pedestal portion 3.

囲繞部51は、台座部3とリング状部材5との係合時、台座部3の周壁部31を覆う化粧用のカバーであり、使用者が台座部3の周壁部31を回してリング状部材5と台座部3との係合を誤って外すことがないよう、周壁部31に直接触れることを防止している。囲繞部51は、その下端部が円環部50の下端部よりも下方に長く延び、かつ、台座部3とリング状部材5との係合時に台座部3の周壁部31の下端部よりも上方に位置するように、その長さが設定されている。これにより、台座部3とリング状部材5との係合時には台座部3の周壁部31の下端部がリング状部材5の囲繞部51の下端部よりも下方に突き出るため、例えば薬剤揮散容器1が誤って台上などに落下した場合において、台座部3が主に台などから衝撃を受ける。ここで、リング状部材5の囲繞部51の下端部が台座部3の周壁部31の下端部よりも下方に突き出ている場合は、落下時にリング状部材5が主に台などから衝撃を受けると、リング状部材5には台座部3との係合が外れる上向きの力が作用するため、衝撃の度合いが大きいと、落下時の衝撃によりリング状部材5が台座部3から外れる恐れがあるが、囲繞部51が周壁部31の下端部よりも上方に位置している本実施形態では、落下時の衝撃を主に台座部3に作用させることで、リング状部材5が台座部3から外れるのを防止している。   The surrounding portion 51 is a cosmetic cover that covers the peripheral wall portion 31 of the pedestal portion 3 when the pedestal portion 3 and the ring-shaped member 5 are engaged, and the user turns the peripheral wall portion 31 of the pedestal portion 3 to form a ring shape. Direct contact with the peripheral wall portion 31 is prevented so that the engagement between the member 5 and the pedestal portion 3 is not accidentally released. The lower end portion of the surrounding portion 51 extends longer than the lower end portion of the annular portion 50, and more than the lower end portion of the peripheral wall portion 31 of the pedestal portion 3 when the pedestal portion 3 and the ring-shaped member 5 are engaged. The length is set so as to be positioned above. Thereby, since the lower end part of the peripheral wall part 31 of the base part 3 protrudes below the lower end part of the surrounding part 51 of the ring-shaped member 5 at the time of engagement with the base part 3 and the ring-shaped member 5, for example, the chemical volatilization container 1 Is accidentally dropped onto a table or the like, the pedestal 3 receives an impact mainly from the table or the like. Here, when the lower end portion of the surrounding portion 51 of the ring-shaped member 5 protrudes below the lower end portion of the peripheral wall portion 31 of the pedestal portion 3, the ring-shaped member 5 receives an impact mainly from the table or the like when dropped. Then, an upward force that disengages from the pedestal portion 3 acts on the ring-shaped member 5, and therefore, if the degree of impact is large, the ring-shaped member 5 may be detached from the pedestal portion 3 due to the impact at the time of dropping. However, in the present embodiment in which the surrounding portion 51 is located above the lower end portion of the peripheral wall portion 31, the ring-shaped member 5 is removed from the pedestal portion 3 by causing the impact at the time of dropping to mainly act on the pedestal portion 3. It prevents it from coming off.

上記構成の第1実施形態の薬剤揮散容器1においては、使用前は薬剤2が蓋部4内に密閉されている一方、使用に際しては、ミシン目44を破断しカバー部材43を開いて揮散孔42を形成することで、各揮散孔42より揮散した薬剤2が外部に放出される。このとき、形成する揮散孔42の数を適宜選択することで、外部に放出される薬剤2の揮散量や匂いの強さを調節できる。また、薬剤2は蓋部4内の揮散孔42よりも下方に位置し、薬剤2が直接手で触れられることが防止されているので、幼児などに対する安全性が高い。   In the drug volatilization container 1 of the first embodiment having the above-described configuration, the drug 2 is sealed in the lid 4 before use, while the perforation 44 is broken and the cover member 43 is opened to open the volatilization hole. By forming 42, the chemical | medical agent 2 volatilized from each volatilization hole 42 is discharge | released outside. At this time, by appropriately selecting the number of volatilization holes 42 to be formed, the volatilization amount and odor intensity of the medicine 2 released to the outside can be adjusted. Moreover, since the chemical | medical agent 2 is located below the volatilization hole 42 in the cover part 4, and the chemical | medical agent 2 is prevented from touching directly with a hand, safety | security with respect to an infant etc. is high.

第1実施形態の薬剤揮散容器1によれば、蓋部4の下端開口を塞ぐ台座部3に対して上方からリング状部材5を被せ、リング状部材5と台座部3の周縁とを係合させることにより、蓋部4内を密閉した状態で蓋部4を台座部3上に固定することができる。このとき、蓋部4は、フランジ部45が台座部3の上面(コンタクトリング37)とリング状部材5の円環部50とで上下から挟持されているので、蓋部4を確実に台座部3に固定できる。よって、使用前や使用中に誤って薬剤揮散容器1が倒れたりした場合でも、台座部3と蓋部4との固定が外れることがなく、また、蓋部4内に収納された薬剤2から発散された水分が外部に漏れる量を抑制できる。また、フランジ部45が台座部3の上面(コンタクトリング37)とリング状部材5の円環部50とで挟持されることで、蓋部4内を良好に密閉することができる。   According to the chemical volatilization container 1 of the first embodiment, the ring-shaped member 5 is covered from above with respect to the pedestal 3 that closes the lower end opening of the lid 4, and the ring-shaped member 5 and the periphery of the pedestal 3 are engaged. By doing so, the lid portion 4 can be fixed on the pedestal portion 3 with the inside of the lid portion 4 sealed. At this time, since the flange portion 45 is sandwiched from above and below by the upper surface (contact ring 37) of the pedestal portion 3 and the annular portion 50 of the ring-shaped member 5, the lid portion 4 is securely attached to the pedestal portion. 3 can be fixed. Therefore, even if the chemical volatilization container 1 is accidentally tilted before or during use, the pedestal 3 and the lid 4 are not fixed, and the chemical 2 stored in the lid 4 can be removed. It is possible to suppress the amount of the released water leaking to the outside. Further, since the flange portion 45 is sandwiched between the upper surface (contact ring 37) of the pedestal portion 3 and the annular portion 50 of the ring-shaped member 5, the inside of the lid portion 4 can be sealed well.

また、台座部3には、蓋部4の収納空間40の内外を連通する連通部38(第1、2の溝部38A,38B)が設けられ、連通部38(第1、2の溝部38A,38B)を介して収納空間40の内外を空気が流通可能になっているので、薬剤揮散容器1の使用前の酸素の消費によって蓋部4内が減圧することが防止され、その結果、蓋部4の一部が凹むことを防止できる。よって、薬剤揮散容器1の見栄えが悪くなることを防止できるため、薬剤2が蓋部4内に未だ残っている未使用の状態で薬剤揮散容器1が廃棄処分されてしまうようなことも防止できる。   Further, the pedestal portion 3 is provided with a communication portion 38 (first and second groove portions 38A and 38B) that communicates the inside and outside of the storage space 40 of the lid portion 4, and the communication portion 38 (first and second groove portions 38A, 38A, 38B), air can flow through the inside and outside of the storage space 40, so that the inside of the lid portion 4 is prevented from being depressurized due to consumption of oxygen before use of the chemical volatilization container 1, and as a result, the lid portion 4 can be prevented from being recessed. Therefore, since the appearance of the chemical volatilization container 1 can be prevented from being deteriorated, it is possible to prevent the chemical volatilization container 1 from being disposed of in an unused state in which the chemical 2 is still left in the lid 4. .

また、台座部3の上面には、貯水溝39が複数設けられているので、時間の経過と共に薬剤2から含有する水分が発散されても、この発散される水分を各貯水溝39に貯留することができる。これにより、水分がコンタクトリング37を超えて薬剤揮散容器1から漏れ出すことを防止できる。   In addition, since a plurality of water storage grooves 39 are provided on the upper surface of the pedestal portion 3, even if the water contained from the medicine 2 diverges with the passage of time, this divergence of water is stored in each water storage groove 39. be able to. Thereby, it can prevent that a water | moisture content leaks out from the chemical volatilization container 1 exceeding the contact ring 37. FIG.

また、台座部3の上面には、蓋部4の内壁面と対向する堰部36が設けられているので、台座部3上に蓋部4を載置する際に、堰部36により蓋部4を最適な位置に位置決めすることができる。また、リング状部材5と台座部3との係合により蓋部4を台座部3上に固定する際に、蓋部4が紙製や薄手のプラスチック製などの柔らかい材質であると、リング状部材5の締め付けにより、蓋部4が内側に押し込まれる恐れがあるが、このとき、堰部36がストッパーとして機能して蓋部4が内側に押し込まれるのが防止されるので、蓋部4の形状を保持できる。また、このとき、蓋部4の内壁面が堰部36の外周面と当接することで蓋部4内をより良好に密閉することができる。   Further, since the dam part 36 facing the inner wall surface of the lid part 4 is provided on the upper surface of the pedestal part 3, when the lid part 4 is placed on the pedestal part 3, the lid part is formed by the dam part 36. 4 can be positioned at an optimum position. Further, when the lid portion 4 is fixed on the pedestal portion 3 by the engagement between the ring-shaped member 5 and the pedestal portion 3, if the lid portion 4 is made of a soft material such as paper or thin plastic, the ring shape The lid 4 may be pushed inward by tightening the member 5, but at this time, the weir part 36 functions as a stopper to prevent the lid 4 from being pushed inward. The shape can be maintained. At this time, the inside of the lid 4 can be better sealed by the inner wall surface of the lid 4 coming into contact with the outer peripheral surface of the weir 36.

また、台座部3の下面には、台座部3およびリング状部材5が係合する回転方向に向けて深く入り込む溝60が設けられているので、リング状部材5に対して台座部3を回転させて両者を係合させる場合には、溝60の鉛直面62に指の爪などを引っ掛けて台座部3を回転させれば、両者を容易に係合させることができる。一方で、両者の係合を外すためにリング状部材5に対して台座部3を上記とは反対方向に回転させる場合には、溝60に指の爪などを引っ掛けても、爪などが溝60の傾斜面61上を滑るために台座部3を回転させることができず、両者の係合を外すことが困難となる。よって、リング状部材5から台座部3を容易に取り外すことを防止できる。   Moreover, since the groove | channel 60 which penetrates deeply toward the rotation direction which the base part 3 and the ring-shaped member 5 engage is provided in the lower surface of the base part 3, the base part 3 is rotated with respect to the ring-shaped member 5. In the case of engaging the two, if the fingernail or the like is hooked on the vertical surface 62 of the groove 60 and the pedestal portion 3 is rotated, the two can be easily engaged. On the other hand, when the pedestal 3 is rotated with respect to the ring-shaped member 5 in the direction opposite to the above in order to disengage the two, even if the fingernail or the like is hooked on the groove 60, the nail or the like is not grooved. The pedestal 3 cannot be rotated in order to slide on the 60 inclined surfaces 61, and it becomes difficult to disengage the two. Therefore, it is possible to prevent the base portion 3 from being easily detached from the ring-shaped member 5.

以上、本発明の第1実施形態について説明したが、第1実施形態の具体的な態様は上記した態様に限定されない。例えば、上記した実施形態では、台座部3の底壁部30の上面に、薬剤2の周囲を囲む環状壁35が設けられているが、必ずしも環状壁35を設ける必要はない。また、台座部3の底壁部30の上面に、環状壁35の周囲を囲む堰部36が設けられているが、必ずしも堰部36を設ける必要はない。また、台座部3の底壁部30の上面にコンタクトリング37を設け、コンタクトリング37とリング状部材5の円環部50とで蓋部4のフランジ部45を上下から挟持しているが、必ずしもコンタクトリング37を設ける必要はなく、台座部3の底壁部30の上面とリング状部材5の円環部50とで蓋部4のフランジ部45を上下から挟持するようにしてもよい。また、連通部38を台座部3に設けているが、必ずしも台座部3に設ける必要はなく、蓋部4がプラスチック製などである場合には、蓋部4の上端面にピンホールを形成することで、このピンホールを連通部38として機能させてもよい。   The first embodiment of the present invention has been described above, but the specific aspect of the first embodiment is not limited to the above-described aspect. For example, in the above-described embodiment, the annular wall 35 surrounding the periphery of the medicine 2 is provided on the upper surface of the bottom wall portion 30 of the pedestal portion 3, but the annular wall 35 is not necessarily provided. Moreover, although the dam part 36 surrounding the circumference | surroundings of the annular wall 35 is provided in the upper surface of the bottom wall part 30 of the base part 3, the dam part 36 does not necessarily need to be provided. Further, a contact ring 37 is provided on the upper surface of the bottom wall portion 30 of the pedestal portion 3, and the flange portion 45 of the lid portion 4 is sandwiched from above and below by the contact ring 37 and the annular portion 50 of the ring-shaped member 5. The contact ring 37 is not necessarily provided, and the flange portion 45 of the lid portion 4 may be sandwiched from above and below by the upper surface of the bottom wall portion 30 of the pedestal portion 3 and the annular portion 50 of the ring-shaped member 5. Moreover, although the communication part 38 is provided in the base part 3, it does not necessarily need to provide in the base part 3, and when the cover part 4 is plastics etc., a pinhole is formed in the upper end surface of the cover part 4. FIG. Thus, this pinhole may function as the communication portion 38.

(第2実施形態)
次に、本発明の第2実施形態について、図25〜図30を参照しつつ説明する。第2実施形態の薬剤揮散容器10が、第1実施形態の薬剤揮散容器1と相違するのは台座部の構成であり、第2実施形態の薬剤揮散容器10も、薬剤2を載置する台座部7の他、台座部7上の薬剤2を覆う蓋部4と、台座部7上に蓋部4を固定するリング状部材5とを備えている。なお、第2実施形態の薬剤揮散容器10の構成において、上記した第1実施形態の構成と対応する構成については同一の符号を付することで説明を省略する。
(Second Embodiment)
Next, a second embodiment of the present invention will be described with reference to FIGS. The chemical volatilization container 10 of the second embodiment is different from the chemical volatilization container 1 of the first embodiment in the configuration of the pedestal, and the chemical volatilization container 10 of the second embodiment is also a pedestal on which the drug 2 is placed. In addition to the portion 7, a lid portion 4 that covers the medicine 2 on the pedestal portion 7 and a ring-shaped member 5 that fixes the lid portion 4 on the pedestal portion 7 are provided. In addition, in the structure of the chemical volatilization container 10 of 2nd Embodiment, description is abbreviate | omitted by attaching | subjecting the same code | symbol about the structure corresponding to the structure of 1st Embodiment mentioned above.

台座部7は、図25〜図29に示すように、第1実施形態と同様、合成樹脂製であって、平面視円形状に形成されており、底壁部30と、底壁部30の周縁から立ち上がる環状の周壁部31とを備えている。周壁部31の内面の上部には、係合部6を構成する雌ネジ部32が設けられており、リング状部材5の雄ネジ部52と螺合することで、台座部7とリング状部材5とが固定される。周壁部31の下端部は、台座部7の下面よりも下方に突き出ている。   As shown in FIGS. 25 to 29, the pedestal portion 7 is made of a synthetic resin and has a circular shape in plan view, as in the first embodiment, and includes a bottom wall portion 30 and a bottom wall portion 30. And an annular peripheral wall portion 31 rising from the periphery. A female screw portion 32 that constitutes the engaging portion 6 is provided on the upper surface of the inner surface of the peripheral wall portion 31. By screwing with the male screw portion 52 of the ring-shaped member 5, the base portion 7 and the ring-shaped member are formed. 5 is fixed. The lower end portion of the peripheral wall portion 31 projects downward from the lower surface of the pedestal portion 7.

底壁部30の中央部には、底壁部30上に載置された薬剤2内に嵌合して薬剤2を底壁部30上に保持するための保持支柱73が設けられている。保持支柱73は、第2実施形態では、底壁部30の上面から突き出る円筒状の筒状体73Aを備え、その上部が薬剤2を貫通して薬剤2から露出している。筒状体73Aの下部には、複数(図示例では3つ)の板状の規制板73Bが筒状体73Aを中心に放射状に設けられており、薬剤2が周方向に回転するのが規制されている。また、筒状体73Aには、鍔部材74が取り外し可能に設けられており、鍔部材74により薬剤2が上下方向に移動するのが規制されている。   At the center of the bottom wall portion 30, a holding column 73 is provided for fitting in the medicine 2 placed on the bottom wall portion 30 and holding the medicine 2 on the bottom wall portion 30. In the second embodiment, the holding column 73 includes a cylindrical tubular body 73 </ b> A protruding from the upper surface of the bottom wall portion 30, and an upper portion thereof penetrates the drug 2 and is exposed from the drug 2. A plurality (three in the illustrated example) of plate-like restriction plates 73B are provided radially around the tubular body 73A at the lower part of the tubular body 73A, and the medicine 2 is restricted from rotating in the circumferential direction. Has been. Further, the cylindrical member 73A is provided with a heel member 74 so as to be removable, and the heel member 74 is restricted from moving the medicine 2 in the vertical direction.

鍔部材74は、図30に示すように、中央に開口を有する円盤状のものである。筒状体73Aは、外周面に複数の係止片73Dが設けられているとともに、各係止片73Dの下方に径の大きい段差部73Cが設けられており、筒状体73Aの各係止片73Dと段差部73Cとの間に鍔部材74の開口を嵌合させて係止片73Dを鍔部材74の上面に係止させることで、鍔部材74が筒状体73Aに取り付けられる。また、鍔部材74を上方に引き抜くことで、筒状体73Aから取り外すことができる。   As shown in FIG. 30, the flange member 74 has a disk shape having an opening at the center. The cylindrical body 73A is provided with a plurality of locking pieces 73D on the outer peripheral surface, and a step portion 73C having a large diameter is provided below each locking piece 73D, and each locking of the cylindrical body 73A. By fitting the opening of the eaves member 74 between the piece 73D and the stepped portion 73C and engaging the engaging piece 73D with the upper surface of the eaves member 74, the eaves member 74 is attached to the cylindrical body 73A. Further, the collar member 74 can be removed from the cylindrical body 73A by pulling upward.

筒状体73Aは、台座部7の底壁部30の中央部が隆起するようにして上方に延びており、その内部は中空であり、かつ、その下端は開口73Eとなっている。筒状体73Aの上端面には、その中央部に連通孔38Cが形成されている。この連通孔38Cは、連通部38を構成しており、第2実施形態では、連通孔38Cおよび筒状体73A内の空洞38Dで蓋部4の収納空間40の内外を連通している。筒状体73Aの外形の大きさは、特に限定されるものではなく、適宜設定することができるが、小さければ小さいほど、その分、薬剤2の容積が増大するので好ましい一方、小さ過ぎると、筒状体73Aが折れやすくなる。また、連通孔38Cの径も、特に限定されるものではなく、適宜設定することができる。   The cylindrical body 73A extends upward so that the central portion of the bottom wall portion 30 of the pedestal portion 7 is raised, the inside thereof is hollow, and the lower end thereof is an opening 73E. A communication hole 38C is formed at the center of the upper end surface of the cylindrical body 73A. The communication hole 38C constitutes a communication part 38. In the second embodiment, the communication hole 38C and the cavity 38D in the cylindrical body 73A communicate with the inside and outside of the storage space 40 of the lid part 4. The size of the outer shape of the cylindrical body 73A is not particularly limited and can be appropriately set. However, the smaller the size, the more preferable the volume of the drug 2 increases. The cylindrical body 73A is easily broken. Further, the diameter of the communication hole 38C is not particularly limited, and can be set as appropriate.

底壁部30の上面には、載置される薬剤2の直径よりも僅かに大きい内径を有する環状の環状壁35が、底壁部30の上面から突き出るようにして設けられている。また、環状壁35の周囲には、環状壁35よりも高さが低く、底壁部30上に載置された蓋部4の内壁面と対向する環状の堰部36が、底壁部30の上面から突き出るようにして設けられている。   On the upper surface of the bottom wall portion 30, an annular annular wall 35 having an inner diameter slightly larger than the diameter of the medicine 2 to be placed is provided so as to protrude from the upper surface of the bottom wall portion 30. In addition, an annular weir portion 36 that is lower than the annular wall 35 and faces the inner wall surface of the lid portion 4 placed on the bottom wall portion 30 is provided around the annular wall 35. It is provided so as to protrude from the upper surface of.

堰部36は、第1実施形態と同様、蓋部4の下端開口の直径よりも僅かに小さい外径を有しており、蓋部4を底壁部30上に載置する際に、蓋部4を最適な位置に位置させる位置決めとして機能する。また、蓋部4を底壁部30上に載置した状態で、リング状部材5と台座部7との係合により蓋部4を台座部7に固定する際に、堰部36がストッパーとして機能して蓋部4の周壁41の下部が内側に押し込まれるのを防ぐことで、蓋部4の周壁41の形状を保持できる。このとき、蓋部4の内壁面が堰部36の外周面と当接することで蓋部4の収納空間40内を良好に密閉することができる。   Similar to the first embodiment, the weir portion 36 has an outer diameter slightly smaller than the diameter of the lower end opening of the lid portion 4, and when the lid portion 4 is placed on the bottom wall portion 30, It functions as positioning for positioning the portion 4 at an optimal position. Further, when the lid portion 4 is fixed to the pedestal portion 7 by the engagement between the ring-shaped member 5 and the pedestal portion 7 with the lid portion 4 placed on the bottom wall portion 30, the dam portion 36 serves as a stopper. The shape of the peripheral wall 41 of the lid part 4 can be maintained by functioning and preventing the lower part of the peripheral wall 41 of the lid part 4 from being pushed inward. At this time, since the inner wall surface of the lid portion 4 is in contact with the outer peripheral surface of the dam portion 36, the inside of the storage space 40 of the lid portion 4 can be satisfactorily sealed.

堰部36の周囲の底壁部30の上面には、圧縮可能なリング状のパッキン70が設けられている。パッキン70は、その内径が堰部36の外径とほぼ同じであるとともに、その外径が周壁部31の内径とほぼ同じに形成されており、堰部36と周壁部31との間に嵌め込まれている。蓋部4が底壁部30上に載置される際、フランジ部45の下面がパッキン70の上面と当接し、フランジ部45は、パッキン70を介して底壁部30とリング状部材5の円環部50とで上下から挟持される。これにより、蓋部4が確実に台座部7に固定されるので、使用時または使用前に薬剤揮散容器10が倒れたりした場合でも、台座部7と蓋部4との固定が外れることが防止されるうえ、フランジ部45が台座部7上のパッキン70と当接することで、フランジ部45が密栓されて蓋部4の収納空間40内が連通部38を除いてほぼ完全に密閉されるので、蓋部4の収納空間40内に貯留される薬剤2から発散された水分が薬剤揮散容器10の外側へ漏れるのを完全に防止することができる。パッキン70の材質としては、例えばポリプロエチレン等を好ましく例示することができる。   A compressible ring-shaped packing 70 is provided on the upper surface of the bottom wall portion 30 around the weir portion 36. The packing 70 has an inner diameter that is substantially the same as the outer diameter of the dam portion 36 and an outer diameter that is substantially the same as the inner diameter of the peripheral wall portion 31, and is fitted between the dam portion 36 and the peripheral wall portion 31. It is. When the lid portion 4 is placed on the bottom wall portion 30, the lower surface of the flange portion 45 comes into contact with the upper surface of the packing 70, and the flange portion 45 is connected to the bottom wall portion 30 and the ring-shaped member 5 via the packing 70. It is clamped from above and below by the annular portion 50. Thereby, since the cover part 4 is reliably fixed to the base part 7, even when the chemical volatilization container 10 falls down during use or before use, the base part 7 and the cover part 4 are prevented from being unfixed. In addition, since the flange portion 45 comes into contact with the packing 70 on the pedestal portion 7, the flange portion 45 is tightly sealed, and the inside of the storage space 40 of the lid portion 4 is almost completely sealed except for the communication portion 38. In addition, it is possible to completely prevent the moisture released from the medicine 2 stored in the storage space 40 of the lid portion 4 from leaking to the outside of the medicine volatilization container 10. As a material of the packing 70, for example, polypropylene can be preferably exemplified.

なお、本実施形態では、堰部36の周囲のフランジ部45と対向する位置にパッキン70を設けているが、パッキン70に代えて、第1実施形態と同様に、堰部36よりも高さが低い環状のコンタクトリング37を設け、コンタクトリング37とリング状部材5の円環部50とでフランジ部45を上下から挟持するようにしてもよい。これによっても、蓋部4を確実に台座部7に固定できるうえ、フランジ部45がコンタクトリング37とリング状部材5の円環部50とで挟持されるので、蓋部4の収納空間40内を液密に密閉することができる。   In the present embodiment, the packing 70 is provided at a position facing the flange portion 45 around the dam portion 36. However, instead of the packing 70, the height is higher than the dam portion 36 as in the first embodiment. An annular contact ring 37 having a low height may be provided, and the flange portion 45 may be sandwiched between the contact ring 37 and the annular portion 50 of the ring-shaped member 5 from above and below. Also by this, the lid portion 4 can be securely fixed to the pedestal portion 7, and the flange portion 45 is sandwiched between the contact ring 37 and the annular portion 50 of the ring-shaped member 5. Can be hermetically sealed.

台座部7の下面には、溝63が少なくとも1つ(例えば3つ)設けられている。各溝63は、本実施形態では、台座部7およびリング状部材5が係合する回転方向の両端が鉛直面64となっており、リング状部材5に対して台座部7を回転させて両者を係合させる場合、および、両者の係合を外すためにリング状部材5に対して台座部7を上記とは反対方向に回転させる場合の双方において、溝63の鉛直面64に指の爪などを引っ掛けて台座部7を回転させやすくなっている。なお、台座部7の下面の各溝63は、第1実施形態と同様に、台座部7およびリング状部材5が係合する回転方向に向けて深く入り込むように形成することもできる。   At least one groove 63 (for example, three) is provided on the lower surface of the base portion 7. In the present embodiment, both ends of the grooves 63 in the rotational direction in which the pedestal portion 7 and the ring-shaped member 5 are engaged are vertical surfaces 64, and both are obtained by rotating the pedestal portion 7 with respect to the ring-shaped member 5. And the fingernail on the vertical surface 64 of the groove 63 both when the base 7 is rotated in the opposite direction to the ring-shaped member 5 in order to disengage the two. It is easy to rotate the pedestal portion 7 by hooking them. In addition, each groove | channel 63 of the lower surface of the base part 7 can also be formed so that it may penetrate deeply toward the rotation direction which the base part 7 and the ring-shaped member 5 engage similarly to 1st Embodiment.

第2実施形態の薬剤揮散容器10においては、リング状部材5の囲繞部51は、その下端部が円環部50の下端部よりも下方に長く延びているが、台座部7とリング状部材5との係合時には、第1実施形態とは異なり、台座部7の周壁部31の下端部よりも下方に位置するように、その長さが設定されている。これにより、台座部7とリング状部材5との係合時にはリング状部材5の囲繞部51の下端部が、台座部7の周壁部31の下端部よりも下方に突き出るため、薬剤揮散容器10を台などの上に置いた際に、台座部7の底壁部30の下面が宙に浮き、保持支柱73(筒状体73A)の下端の開口73Eが閉鎖されるのが防止されている。また、リング状部材5の囲繞部51の下端部は、凸部54と凹部55とが交互に連続して配された略波形状に形成されており、各凹部55が薬剤揮散容器10を台などの上に置いた際に、空気の通気孔8として機能する(図18〜図23に示す)。これにより、連通部38(連通孔38Cおよび空洞38D)を介して蓋部4の収納空間40の内外を空気が良好に通気可能になっている。なお、本実施形態では、リング状部材5の囲繞部51の下端部を略波形状に形成しているが、リング状部材5の囲繞部51の下端部に凹部55が形成されるのであれば、種々の形状に形成することができる。また、リング状部材5の囲繞部51の下端部に凹部55を形成することで、リング状部材5に通気孔8を形成しているが、リング状部材5の囲繞部51に貫通口を形成することで、この貫通口を通気孔8として機能させてもよい。   In the chemical volatilization container 10 of the second embodiment, the surrounding portion 51 of the ring-shaped member 5 has a lower end extending longer than a lower end of the annular portion 50, but the pedestal portion 7 and the ring-shaped member. Unlike the first embodiment, the length is set so as to be positioned below the lower end portion of the peripheral wall portion 31 of the pedestal portion 7 when engaged with 5. Thereby, since the lower end part of the surrounding part 51 of the ring-shaped member 5 protrudes below the lower end part of the peripheral wall part 31 of the base part 7 at the time of engagement of the base part 7 and the ring-shaped member 5, the chemical volatilization container 10 Is placed on a table or the like, the lower surface of the bottom wall portion 30 of the pedestal portion 7 is suspended in the air, and the opening 73E at the lower end of the holding column 73 (cylindrical body 73A) is prevented from being closed. . Further, the lower end portion of the surrounding portion 51 of the ring-shaped member 5 is formed in a substantially wave shape in which convex portions 54 and concave portions 55 are alternately and continuously arranged, and each concave portion 55 supports the drug volatilization container 10. When it is placed on the above, it functions as an air vent 8 (shown in FIGS. 18 to 23). Thereby, air can be favorably ventilated inside and outside the storage space 40 of the lid portion 4 through the communication portion 38 (the communication hole 38C and the cavity 38D). In the present embodiment, the lower end portion of the surrounding portion 51 of the ring-shaped member 5 is formed in a substantially wave shape. However, if the concave portion 55 is formed in the lower end portion of the surrounding portion 51 of the ring-shaped member 5. It can be formed in various shapes. Further, the recess 55 is formed in the lower end portion of the surrounding portion 51 of the ring-shaped member 5, so that the vent hole 8 is formed in the ring-shaped member 5, but the through hole is formed in the surrounding portion 51 of the ring-shaped member 5. By doing so, this through-hole may function as the vent hole 8.

この第2実施形態の薬剤揮散容器10によれば、蓋部4を台座部7上に固定する際、蓋部4は、フランジ部45がパッキン70を介して台座部7の上面とリング状部材5の円環部50とで上下から挟持されるので、蓋部4を確実に台座部7に固定でき、かつ、蓋部4の収納空間40内をほぼ完全に密閉することができる。よって、使用前や使用中に誤って薬剤揮散容器10が倒れたりした場合でも、台座部7と蓋部4との固定が外れることがないうえ、その際、蓋部4内に貯留された薬剤2から発散された水分が外部に漏れることを完全に防止できる。   According to the chemical volatilization container 10 of the second embodiment, when the lid portion 4 is fixed on the pedestal portion 7, the lid portion 4 includes the flange portion 45 via the packing 70 and the upper surface of the pedestal portion 7 and the ring-shaped member. Therefore, the lid 4 can be securely fixed to the base 7 and the storage space 40 of the lid 4 can be almost completely sealed. Therefore, even if the chemical volatilization container 10 is accidentally tilted before or during use, the pedestal 7 and the lid 4 are not detached from each other, and the drug stored in the lid 4 at that time. It is possible to completely prevent the moisture emitted from 2 from leaking outside.

また、台座部7の保持支柱73に、蓋部4の収納空間40の内外を連通する連通部38(連通孔38C,空洞38D)を設けることで、第1実施形態と比較して、蓋部4の収納空間40内をほぼ完全な密閉状態としたうえで、連通部38(連通孔38C,空洞38D)を介して収納空間40の内外を空気が流通可能になっている。よって、薬剤揮散容器10の使用前の酸素の消費によって蓋部4内が減圧することが防止される結果、蓋部4の一部が凹むことを防止でき、薬剤揮散容器10の見栄えが悪くなることを防止できるため、薬剤2が蓋部4内に未だ残っている未使用の状態で薬剤揮散容器10が廃棄処分されてしまうようなことも防止できる。   Further, by providing the holding column 73 of the pedestal portion 7 with the communication portion 38 (communication hole 38C, cavity 38D) that communicates the inside and outside of the storage space 40 of the lid portion 4, compared to the first embodiment, the lid portion In addition, the inside of the storage space 40 can be circulated through the inside and outside of the storage space 40 through the communication portion 38 (communication hole 38C, cavity 38D). Therefore, as a result of preventing the inside of the lid part 4 from being depressurized due to consumption of oxygen before use of the chemical volatilization container 10, it is possible to prevent a part of the lid part 4 from being dented and the appearance of the chemical volatilization container 10 is deteriorated. Therefore, it is possible to prevent the chemical volatilization container 10 from being disposed of in an unused state where the chemical 2 is still left in the lid 4.

以上、本発明の第2実施形態について説明したが、第2実施形態の具体的な態様は上記した態様に限定されない。例えば、上記した実施形態では、台座部7の底壁部30の上面に、薬剤2の周囲を囲む環状壁35が設けられているが、必ずしも環状壁35を設ける必要はない。また、台座部7の底壁部30の上面に、環状壁35の周囲を囲む堰部36が設けられているが、必ずしも堰部36を設ける必要はない。また、連通部38を台座部7の保持支柱73に設けているが、必ずしも台座部7に設ける必要はなく、蓋部4がプラスチック製などである場合には、蓋部4の上端面にピンホールを形成することで、このピンホールを連通部38として機能させてもよい。   As mentioned above, although 2nd Embodiment of this invention was described, the specific aspect of 2nd Embodiment is not limited to an above-described aspect. For example, in the above-described embodiment, the annular wall 35 surrounding the periphery of the medicine 2 is provided on the upper surface of the bottom wall portion 30 of the pedestal portion 7, but the annular wall 35 is not necessarily provided. Moreover, although the dam part 36 surrounding the circumference | surroundings of the annular wall 35 is provided in the upper surface of the bottom wall part 30 of the base part 7, the dam part 36 does not necessarily need to be provided. Further, although the communication portion 38 is provided on the holding column 73 of the pedestal portion 7, it is not necessarily provided on the pedestal portion 7, and when the lid portion 4 is made of plastic or the like, a pin is provided on the upper end surface of the lid portion 4. By forming a hole, this pinhole may function as the communication portion 38.

1,10 薬剤揮散容器
2 薬剤
3,7 台座部
4 蓋部
5 リング状部材
8 通気孔
31 周壁部
32 雌ネジ部
36 堰部
37 コンタクトリング
38 連通部
38A 第1の溝
38B 第2の溝
38C 連通孔
38D 空洞
39 貯水溝
40 収納空間
41 周壁
42 揮散孔
45 フランジ部
52 雄ネジ部
60,63 溝
70 パッキン
73 保持支柱
73A 筒状体
DESCRIPTION OF SYMBOLS 1,10 Chemical volatilization container 2 Chemical | medical agent 3,7 Base part 4 Lid part 5 Ring-shaped member 8 Ventilation hole 31 Peripheral wall part 32 Female thread part 36 Weir part 37 Contact ring 38 Communication part 38A 1st groove | channel 38B 2nd groove | channel 38C Communication hole 38D Cavity 39 Water storage groove 40 Storage space 41 Peripheral wall 42 Volatilization hole 45 Flange part 52 Male thread part 60, 63 Groove 70 Packing 73 Holding support 73A Cylindrical body

Claims (12)

下端が開口し内部に薬剤を収納可能な空間を有し、周壁に薬剤を揮散させる揮散孔を有する蓋部と、
前記薬剤を載置するとともに、前記薬剤を収納した前記蓋部の下端開口を塞ぐ台座部と、
前記台座部の周縁と係合し、前記台座部上に前記蓋部を固定するリング状部材と、を備え、
前記蓋部の下端開口の周縁には外方に延出するフランジ部が設けられ、
前記リング状部材は、前記台座部の上面とで前記フランジ部を上下から挟持しており、
前記台座部には、前記蓋部の収納空間の内外を連通する連通部が設けられている薬剤揮散容器。
A lid having a space where a lower end is opened and a medicine can be stored inside, and a volatilization hole for volatilizing the medicine on a peripheral wall;
A pedestal part for placing the medicine and closing a lower end opening of the lid part containing the medicine;
A ring-shaped member that engages with the periphery of the pedestal portion and fixes the lid portion on the pedestal portion;
A flange portion extending outward is provided on the periphery of the lower end opening of the lid portion,
The ring-shaped member sandwiches the flange portion from above and below with the upper surface of the pedestal portion ,
The chemical volatilization container in which the base part is provided with a communication part that communicates the inside and outside of the storage space of the lid part .
前記台座部には、上面から突き出る環状のコンタクトリングが設けられており、
前記フランジ部は、前記コンタクトリングと前記リング状部材とで上下から挟持される請求項に記載の薬剤揮散容器。
The pedestal is provided with an annular contact ring protruding from the upper surface,
The drug volatilization container according to claim 1 , wherein the flange portion is sandwiched from above and below by the contact ring and the ring-shaped member.
前記台座部の上面には、リング状のパッキンが設けられており、
前記フランジ部は、前記パッキンを介して前記台座部と前記リング状部材とで上下から挟持される請求項に記載の薬剤揮散容器。
On the upper surface of the pedestal portion, a ring-shaped packing is provided,
The drug volatilization container according to claim 1 , wherein the flange portion is sandwiched from above and below by the pedestal portion and the ring-shaped member via the packing.
前記台座部には、前記台座部の上面から突き出て前記薬剤を貫通する保持支柱が設けられており、
前記保持支柱は、下端が開口した筒状体からなり、前記連通部は、前記保持支柱に設けられている請求項1〜3のいずれかに記載の薬剤揮散容器。
The pedestal part is provided with a holding column that protrudes from the upper surface of the pedestal part and penetrates the medicine,
The drug volatilization container according to any one of claims 1 to 3 , wherein the holding column is formed of a cylindrical body having an open lower end, and the communication portion is provided on the holding column.
前記リング状部材は、前記台座部との係合時に、前記リング状部材の下端部が前記台座部の下端部よりも下方に突き出ており、
前記リング状部材には、前記連通部と通気可能な通気孔が設けられている請求項に記載の薬剤揮散容器。
When the ring-shaped member is engaged with the pedestal portion, the lower end portion of the ring-shaped member protrudes below the lower end portion of the pedestal portion,
The chemical volatilization container according to claim 4 , wherein the ring-shaped member is provided with a vent hole that can ventilate the communication portion.
前記台座部には、前記台座部の上面から突き出て前記蓋部の内壁面と対向する環状の堰部が設けられている請求項1〜のいずれかに記載の薬剤揮散容器。 The drug volatilization container according to any one of claims 1 to 5 , wherein the pedestal portion is provided with an annular weir portion that protrudes from the upper surface of the pedestal portion and faces the inner wall surface of the lid portion. 前記連通部は、前記コンタクトリングに設けられている請求項に記載の薬剤揮散容器。 The chemical volatilization container according to claim 2 , wherein the communication part is provided in the contact ring. 前記台座部の上面には、前記薬剤の周囲に、前記薬剤から吐き出されて遊離した水分を貯留するための貯水溝が1つまたは複数設けられている請求項に記載の薬剤揮散容器。 The drug volatilization container according to claim 7 , wherein one or a plurality of water storage grooves are provided on an upper surface of the pedestal portion to store water discharged from the drug and released around the drug. 前記台座部には、前記台座部の上面から突き出て前記蓋部の内壁面と対向する環状の堰部が設けられている請求項に記載の薬剤揮散容器。 The chemical volatilization container according to claim 8 , wherein the pedestal portion is provided with an annular weir portion that protrudes from the upper surface of the pedestal portion and faces the inner wall surface of the lid portion. 前記1つまたは複数の貯水溝は、前記コンタクトリングと前記堰部との間に設けられている請求項に記載の薬剤揮散容器。 The chemical volatilization container according to claim 9 , wherein the one or more water storage grooves are provided between the contact ring and the weir part. 前記台座部は、前記フランジ部を囲繞する周壁部を有し、前記周壁部の下端部は、前記台座部の下面よりも突き出ており、かつ、前記リング状部材の係合時に前記リング状部材の下端部よりも下方に突き出ている請求項7〜10のいずれかに記載の薬剤揮散容器。 The pedestal portion has a peripheral wall portion surrounding the flange portion, and a lower end portion of the peripheral wall portion protrudes from a lower surface of the pedestal portion, and the ring-shaped member is engaged with the ring-shaped member. The chemical volatilization container in any one of Claims 7-10 which protrudes below rather than the lower end part. 前記台座部および前記リング状部材は、雌ネジ部および雄ネジ部の螺合により互いに装着され、
前記台座部の下面には、前記台座部および前記リング状部材を装着する回転方向に向けて深く傾斜する溝が1つまたは複数設けられている請求項1〜11のいずれかに記載の薬剤揮散容器。
The pedestal portion and the ring-shaped member are attached to each other by screwing of the female screw portion and the male screw portion,
The drug volatilization according to any one of claims 1 to 11 , wherein one or a plurality of grooves that are deeply inclined toward a rotation direction in which the pedestal part and the ring-shaped member are mounted are provided on a lower surface of the pedestal part. container.
JP2012235905A 2012-08-06 2012-10-25 Chemical volatilization container Active JP6076033B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012235905A JP6076033B2 (en) 2012-08-06 2012-10-25 Chemical volatilization container

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012174340 2012-08-06
JP2012174340 2012-08-06
JP2012235905A JP6076033B2 (en) 2012-08-06 2012-10-25 Chemical volatilization container

Publications (2)

Publication Number Publication Date
JP2014050666A JP2014050666A (en) 2014-03-20
JP6076033B2 true JP6076033B2 (en) 2017-02-08

Family

ID=50609727

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012235905A Active JP6076033B2 (en) 2012-08-06 2012-10-25 Chemical volatilization container

Country Status (1)

Country Link
JP (1) JP6076033B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022112039A (en) * 2021-01-21 2022-08-02 小林製薬株式会社 Chemical solution volatilization apparatus
JP7636181B2 (en) * 2021-01-21 2025-02-26 小林製薬株式会社 Chemical Solution Vaporizer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5254607Y2 (en) * 1973-02-12 1977-12-10
JPS5713068Y2 (en) * 1977-05-13 1982-03-16
JPS5634749Y2 (en) * 1977-05-13 1981-08-17
JPS571950Y2 (en) * 1979-03-16 1982-01-13
JPS55142471U (en) * 1979-03-28 1980-10-13
JPS60929Y2 (en) * 1979-10-15 1985-01-11 凸版印刷株式会社 air freshener container
JPS601721Y2 (en) * 1980-06-30 1985-01-18 日東電工株式会社 Containers for volatile active substances
JPH0511867Y2 (en) * 1989-03-28 1993-03-25
JP3741034B2 (en) * 2001-11-29 2006-02-01 フマキラー株式会社 Chemical volatilization device
JP5627955B2 (en) * 2010-08-30 2014-11-19 エステー株式会社 Volatilization equipment
JP6073093B2 (en) * 2012-09-07 2017-02-01 小林製薬株式会社 Chemical volatilization container

Also Published As

Publication number Publication date
JP2014050666A (en) 2014-03-20

Similar Documents

Publication Publication Date Title
KR102436698B1 (en) Specimen container
CN109125779B (en) Volatilization container
JP6073093B2 (en) Chemical volatilization container
JP6076033B2 (en) Chemical volatilization container
JP5389533B2 (en) Drug container with lock lid
WO2012161111A1 (en) Application container
JP5302754B2 (en) Air freshener container
WO2021204081A1 (en) Fragrance liquid container
KR20190071291A (en) Tube type cosmetic contaniner and cap for the same
JP2012040254A (en) Aromatic agent container
JP6377462B2 (en) Drug container and chemical volatilizer
CN211272615U (en) Air purification device and inner container capable of automatically batching
JP2016032526A (en) Brush case
JP7237132B2 (en) scent sample container
CN115943108B (en) Aromatherapy liquid container
JP4816720B2 (en) Volatile substance emitter and manufacturing method
JP6377461B2 (en) Drug volatilizer and outer case
JP5036151B2 (en) Drainage lid with slime control function
JP2022136672A (en) scent sample container
JP6373689B2 (en) Drug container and chemical volatilizer
JP2009082248A (en) Chemical volatilization device
JP2005021229A (en) Aromatic substance container
WO2014208531A1 (en) Chemical agent volatizer and chemical agent container
KR200379603Y1 (en) Safety plug and receptacle of structure
JP2566257Y2 (en) Deodorant container

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150928

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160921

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160927

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161118

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20161220

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170110

R150 Certificate of patent or registration of utility model

Ref document number: 6076033

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250